Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Research article

Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts

Authors: Annette Masuch, Nele Friedrich, Johannes Roth, Matthias Nauck, Ulrich Alfons Müller, Astrid Petersmann

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

Measurement of gylcated hemoglobin A1c (HbA1c) plays a central role in monitoring quality of antidiabetic therapy and in the diagnosis of diabetes. Several studies report increased levels of HbA1c in nondiabetic elderly. However, this observation did not reach incorporation into daily clinical practice or the respective guidelines. The present study aimed to evaluate HbA1c levels in relation to age in two independent population-based cohorts and to derive age-specific reference intervals.

Methods

Four thousand two hundred sixty three participants from the Study of Health in Pomerania (SHIP-0) and 4402 participants from the independent study SHIP-Trend were included. HbA1c was determined by means of high-performance liquid chromatography. Multivariable linear regression models were performed. Reference intervals for HbA1c were determined.

Results

Reference intervals were derived from a healthy subpopulation with the upper reference limit (URL) for HbA1c of 42.1 mmol/Mol (6.0%) for individuals aged 20–39 years increasing to 43.2 mmol/Mol (6.1%) for individuals aged 40–59 years. For people aged ≥60 years the URL was 47.5 mmol/Mol (6.5%). In both study populations an increase in HbA1c with age was observed. ANOVA revealed up to 8.5 mmol/Mol (0.77%) or 7.3 mmol/Mol (0.68%) higher estimated mean levels of HbA1c in the oldest compared to the youngest age group in SHIP-0 or SHIP-trend, respectively. Linear regression analyses confirmed the positive associations of HbA1c with age which was independent of BMI

Conclusion

The present study confirmed the previously observed increase of HbA1c with increasing age in non-diabetic individuals. As a consequence age-dependent reference values for HbA1c were derived from two large and well defined reference populations. Implementation of them into daily practice may improve patient care and diagnosis of diabetes and reduce the risk of misdiagnosis and subsequent overtreatment of diabetes in elderly patients.
Literature
1.
go back to reference Higgins T. HbA(1c)--an analyte of increasing importance. Clin Biochem. 2012;45:1038–45.CrossRef Higgins T. HbA(1c)--an analyte of increasing importance. Clin Biochem. 2012;45:1038–45.CrossRef
2.
go back to reference Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008;112:4284–91.CrossRef Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 2008;112:4284–91.CrossRef
3.
go back to reference An G, Widness JA, Mock DM, Veng-Pedersen P. A novel physiology-based mathematical model to estimate red blood cell lifespan in different human age groups. AAPS J. 2016;18:1182–91.CrossRef An G, Widness JA, Mock DM, Veng-Pedersen P. A novel physiology-based mathematical model to estimate red blood cell lifespan in different human age groups. AAPS J. 2016;18:1182–91.CrossRef
4.
go back to reference Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care. 2004;27:931–5.CrossRef Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care. 2004;27:931–5.CrossRef
5.
go back to reference Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin a(1c) in the management of diabetes. J Diabetes. 2009;(1):9–17. Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin a(1c) in the management of diabetes. J Diabetes. 2009;(1):9–17.
6.
go back to reference Rohlfing CL, Wiedmeyer H-M, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes control and complications trial. Diabetes Care. 2002;25:275–8.CrossRef Rohlfing CL, Wiedmeyer H-M, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes control and complications trial. Diabetes Care. 2002;25:275–8.CrossRef
7.
go back to reference The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT research group. Diabetes. 1986;35:530–45.CrossRef The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT research group. Diabetes. 1986;35:530–45.CrossRef
8.
go back to reference Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and Management of Diabetes Mellitus. Diabetes Care. 2011;34:e61–99.CrossRef Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and Management of Diabetes Mellitus. Diabetes Care. 2011;34:e61–99.CrossRef
9.
go back to reference Penttilä I, Penttilä K, Holm P, Laitinen H, Ranta P, Törrönen J, et al. Methods, units and quality requirements for the analysis of haemoglobin A1c in diabetes mellitus. World J Methodol. 2016;6:133–42.CrossRef Penttilä I, Penttilä K, Holm P, Laitinen H, Ranta P, Törrönen J, et al. Methods, units and quality requirements for the analysis of haemoglobin A1c in diabetes mellitus. World J Methodol. 2016;6:133–42.CrossRef
10.
go back to reference UK Prospective Diabetes Study (UKPDS). XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med J Br Diabet Assoc. 1994;11:534–44.CrossRef UK Prospective Diabetes Study (UKPDS). XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med J Br Diabet Assoc. 1994;11:534–44.CrossRef
13.
go back to reference American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes Publ Am Diabetes Assoc. 2015;33:97–111. American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes Publ Am Diabetes Assoc. 2015;33:97–111.
14.
go back to reference Davidson MB. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979;28:688–705.CrossRef Davidson MB. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 1979;28:688–705.CrossRef
15.
go back to reference Arnetz BB, Kallner A, Theorell T. The influence of aging on hemoglobin A1c (HbA1c). J Gerontol. 1982;37:648–50.CrossRef Arnetz BB, Kallner A, Theorell T. The influence of aging on hemoglobin A1c (HbA1c). J Gerontol. 1982;37:648–50.CrossRef
16.
go back to reference Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The telecom Study. Diabetologia. 1989;32:864–9.CrossRef Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The telecom Study. Diabetologia. 1989;32:864–9.CrossRef
17.
go back to reference Hashimoto Y, Futamura A, Ikushima M. Effect of aging on HbA1c in a working male Japanese population. Diabetes Care. 1995;18:1337–40.CrossRef Hashimoto Y, Futamura A, Ikushima M. Effect of aging on HbA1c in a working male Japanese population. Diabetes Care. 1995;18:1337–40.CrossRef
18.
go back to reference Yang YC, Lu FH, Wu JS, Chang CJ. Age and sex effects on HbA1c. A study in a healthy Chinese population. Diabetes Care. 1997;20:988–91.CrossRef Yang YC, Lu FH, Wu JS, Chang CJ. Age and sex effects on HbA1c. A study in a healthy Chinese population. Diabetes Care. 1997;20:988–91.CrossRef
19.
go back to reference Carrera T, Bonamusa L, Almirall L, Navarro JM. Should age and sex be taken into account in the determination of HbA1c reference range? Diabetes Care. 1998;21:2193–4.CrossRef Carrera T, Bonamusa L, Almirall L, Navarro JM. Should age and sex be taken into account in the determination of HbA1c reference range? Diabetes Care. 1998;21:2193–4.CrossRef
20.
go back to reference Nuttall FQ. Effect of age on the percentage of hemoglobin A1c and the percentage of total glycohemoglobin in non-diabetic persons. J Lab Clin Med. 1999;134:451–3.CrossRef Nuttall FQ. Effect of age on the percentage of hemoglobin A1c and the percentage of total glycohemoglobin in non-diabetic persons. J Lab Clin Med. 1999;134:451–3.CrossRef
21.
go back to reference Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham offspring Study and the National Health and nutrition examination survey 2001-2004. Diabetes Care. 2008;31:1991–6.CrossRef Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham offspring Study and the National Health and nutrition examination survey 2001-2004. Diabetes Care. 2008;31:1991–6.CrossRef
22.
go back to reference Roth J, Müller N, Lehmann T, Heinemann L, Wolf G, Müller UA. HbA1c and age in non-diabetic subjects: An ignored association? Exp Clin Endocrinol Diabetes. 2016;124(10):637-642. Roth J, Müller N, Lehmann T, Heinemann L, Wolf G, Müller UA. HbA1c and age in non-diabetic subjects: An ignored association? Exp Clin Endocrinol Diabetes. 2016;124(10):637-642.
23.
go back to reference Timiras PS. Physiological basis of aging and geriatrics, fourth edition: CRC Press; 2007. Timiras PS. Physiological basis of aging and geriatrics, fourth edition: CRC Press; 2007.
24.
go back to reference Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 Diabetes. JAMA. 2016;315:1034–45.CrossRef Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 Diabetes. JAMA. 2016;315:1034–45.CrossRef
25.
go back to reference Müller N, Khunti K, Kuss O, Lindblad U, Nolan JJ, Rutten GE, et al. Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study. Acta Diabetol. 2017;54:209–14.CrossRef Müller N, Khunti K, Kuss O, Lindblad U, Nolan JJ, Rutten GE, et al. Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study. Acta Diabetol. 2017;54:209–14.CrossRef
26.
go back to reference Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40:294–307.CrossRef Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40:294–307.CrossRef
27.
go back to reference Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–9.CrossRef Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–9.CrossRef
28.
go back to reference Bundesärztekammer. Richtlinien der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Dtsch Ärztebl. 2014;111:A1583–618. Bundesärztekammer. Richtlinien der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Dtsch Ärztebl. 2014;111:A1583–618.
29.
go back to reference Stone CJ, Koo CY. Additive splines in statistics. In: Proceedings of the statistical computing section. Washington, D.C.: American Statistical Association. p. 1985. Stone CJ, Koo CY. Additive splines in statistics. In: Proceedings of the statistical computing section. Washington, D.C.: American Statistical Association. p. 1985.
30.
go back to reference Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care. 1998;21:261–4.CrossRef Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care. 1998;21:261–4.CrossRef
31.
go back to reference Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia. 1990;33:208–15.CrossRef Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia. 1990;33:208–15.CrossRef
32.
go back to reference Jiao Y, Okumiya T, Saibara T, Park K, Sasaki M. Abnormally decreased HbA1c can be assessed with erythrocyte Creatine in patients with a shortened erythrocyte age. Diabetes Care. 1998;21:1732–5.CrossRef Jiao Y, Okumiya T, Saibara T, Park K, Sasaki M. Abnormally decreased HbA1c can be assessed with erythrocyte Creatine in patients with a shortened erythrocyte age. Diabetes Care. 1998;21:1732–5.CrossRef
33.
go back to reference Beltran Del Rio M, Tiwari M, Amodu LI, Cagliani J, Rodriguez Rilo HL. Glycated hemoglobin, plasma glucose, and erythrocyte aging. J Diabetes Sci Technol. 2016;10:1303–7.CrossRef Beltran Del Rio M, Tiwari M, Amodu LI, Cagliani J, Rodriguez Rilo HL. Glycated hemoglobin, plasma glucose, and erythrocyte aging. J Diabetes Sci Technol. 2016;10:1303–7.CrossRef
34.
go back to reference Franco RS. The measurement and importance of red cell survival. Am J Hematol. 2009;84:109–14.CrossRef Franco RS. The measurement and importance of red cell survival. Am J Hematol. 2009;84:109–14.CrossRef
36.
go back to reference Linehan E, Fitzgerald DC. Ageing and the immune system: focus on macrophages. Eur J Microbiol Immunol. 2015;5:14–24.CrossRef Linehan E, Fitzgerald DC. Ageing and the immune system: focus on macrophages. Eur J Microbiol Immunol. 2015;5:14–24.CrossRef
37.
go back to reference Fairweather-Tait SJ, Wawer AA, Gillings R, Jennings A, Myint PK. Iron status in the elderly. Mech Ageing Dev. 2014;136–137:22–8.CrossRef Fairweather-Tait SJ, Wawer AA, Gillings R, Jennings A, Myint PK. Iron status in the elderly. Mech Ageing Dev. 2014;136–137:22–8.CrossRef
38.
go back to reference Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999;19:357–77.CrossRef Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999;19:357–77.CrossRef
39.
go back to reference Lang F, Erythrocytes FM. Physiology and pathophysiology. In: World scientific publishing co Inc; 2012. Lang F, Erythrocytes FM. Physiology and pathophysiology. In: World scientific publishing co Inc; 2012.
40.
go back to reference Sircar M, Bhatia A, Munshi M. Review of hypoglycemia in the older adult: clinical implications and management. Can J Diabetes. 2016;40:66–72.CrossRef Sircar M, Bhatia A, Munshi M. Review of hypoglycemia in the older adult: clinical implications and management. Can J Diabetes. 2016;40:66–72.CrossRef
41.
go back to reference Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.CrossRef Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.CrossRef
Metadata
Title
Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts
Authors
Annette Masuch
Nele Friedrich
Johannes Roth
Matthias Nauck
Ulrich Alfons Müller
Astrid Petersmann
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2019
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-019-0338-7

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue